MedTrace Logo

Mpox Paediatric and Adolescent Clinical Study

NCT05947786 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-07-17

No results posted yet for this study

Summary

The goal of this multicentre, observational study on mpox in infants, children and adolescents is to increase knowledge about mpox infection and its associated disease in infants, children and adolescents. This will be done through the development of a harmonized system that will allow standard collection of information on demographics, clinical symptoms, clinical course, treatments and outcomes. The study will be carried out in three potential phases: Phase 1 entails the rapid development of an online paediatric registry collecting anonymised data from routine care on infants, children and adolescents with laboratory-confirmed mpox virus infection. If warranted, the study will proceed to Phase 2, an enhanced observational study of children and adolescents with confirmed mpox virus infection, if more detailed prospective data collection would aid the public health response. There is also the potential to initiate Phase 3, comprising of nested sub-studies to investigate specific research questions in this population.

Conditions

  • Monkey Pox
  • Monkeypox

Sponsors & Collaborators

  • University College, London

    collaborator OTHER

  • European University Cyprus

    collaborator OTHER

  • Servicio Madrileño de Salud, Madrid, Spain

    collaborator OTHER

  • European Commission

    collaborator OTHER

  • PENTA Foundation

    lead NETWORK

Eligibility

Min Age
0 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-17
Primary Completion
2025-07-31
Completion
2025-07-31

Countries

  • Greece
  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05947786 on ClinicalTrials.gov